Pharmaceuticals Middle East

Middle East Psoriasis Treatment Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Middle East Psoriasis Treatment Market Industry Trends and Forecast to 2034: Segmented by (Drug Class, Severity, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Middle East · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $1.26 Bn Placeholder estimate
Estimate 2025 $1.36 Bn 4% of the global market
Projected 2034 $2.73 Bn 101.6% Adds $1.38 Bn over 9 forecast years
CAGR 2025–2034 8.1% Faster than 39% of 180 Pharmaceuticals markets here
Key players 6 +1
  • Middle East is 3.95% of the global market.
  • Among regions, the largest is North America at $18.91 Bn.
  • Fastest growing: Africa at 8.6% a year.
  • Middle East ranks 5th of 6 by size among regions.

Market size projection

Middle East

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$1.38 Bn total, 2026–2034

Year-by-year market size, 2024–2034
Psoriasis Treatment Market market size by year, Middle East
YearMarket sizeChange that yearSince 2025
2024 (estimate) $1.26 Bn — —
2025 (base) $1.36 Bn +$101.7 Mn —
2026 (forecast) $1.47 Bn +$109.9 Mn +8.1%
2027 (forecast) $1.59 Bn +$118.8 Mn +16.9%
2028 (forecast) $1.71 Bn +$128.4 Mn +26.3%
2029 (forecast) $1.85 Bn +$138.8 Mn +36.6%
2030 (forecast) $2.00 Bn +$150.1 Mn +47.6%
2031 (forecast) $2.17 Bn +$162.2 Mn +59.6%
2032 (forecast) $2.34 Bn +$175.4 Mn +72.5%
2033 (forecast) $2.53 Bn +$189.6 Mn +86.5%
2034 (forecast) $2.73 Bn +$204.9 Mn +101.6%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Middle East Psoriasis Treatment Market Analysis at a glance
Market size, 2025$1.36 Bn placeholder estimate
Forecast, 2034$2.73 Bn placeholder estimate
Growth (CAGR), 2025–20348.1% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsDrug class, severity and end user (see all)
Key playersJohnson & Johnson, AbbVie Inc., Novartis AG, Eli Lilly and Company, UCB and 1 more (see all)
Active clinical trials3 in Middle EastSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Middle East. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Middle East Psoriasis Treatment Market Analysis Executive Summary

Psoriasis treatments clear red, scaly skin patches using creams, light therapy, pills and biologic injections.

Key segments of the psoriasis Treatment market include drug class (IL-17 Inhibitors, IL-23 Inhibitors and TNF Inhibitors) and severity (Mild and Moderate to Severe).

Bar chart: Middle East Psoriasis Treatment market size, 2024–2034, placeholder estimates. $1.26 Bn in 2024, $1.36 Bn in 2025 and $2.73 Bn in 2034, 8.1% CAGR.
Middle East Psoriasis Treatment market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Middle East Psoriasis Treatment Market Dynamics

Market Growth Drivers

Rising interest in appearance, social media, more affordable treatments and new minimally invasive options are driving the psoriasis Treatment market. More clinics and chains are opening in fast-growing cities.

Opportunity

Treatments for men, at-home options, digital consultations and growth in Asia and the Middle East give the psoriasis Treatment market room to grow.

Market Restraints

Treatments are mostly paid out of pocket, results and safety vary between providers, and economic slowdowns can reduce spending on the psoriasis Treatment market.

Competitive Landscape for Psoriasis Treatment Market in Middle East

The psoriasis Treatment market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Psoriasis Treatment Market in Middle East

Psoriasis Treatment in Middle East: rules, payment and research

In some of the countries we cover here, medicines are approved by SFDA (Saudi Arabia)⁠[1] and EDE (UAE)⁠[2]. How care is paid for in some of these countries: free public care and CHI-regulated insurance (Saudi Arabia)⁠[3] and mandatory health insurance (UAE)⁠[4]. ClinicalTrials.gov lists 3 studies on Psoriasis Treatment that are recruiting, active or about to start in Middle East.⁠[5]

[1] Saudi Food and Drug Authority. Checked 14 Nov 2026.

[2] Emirates Drug Establishment. Checked 14 Nov 2026.

[3] Council of Health Insurance. Checked 14 Nov 2026.

[4] Ministry of Human Resources and Emiratisation. Checked 14 Nov 2026.

[5] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Middle East. Retrieved 12 Nov 2026.

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for psoriasis Treatment. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Middle East.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Psoriasis Treatment right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Psoriasis Treatment in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Psoriasis Treatment market in Middle East?
Placeholder estimate: about $1.36 Bn in 2025, rising to about $2.73 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Psoriasis Treatment market in Middle East growing?
Placeholder estimate: about 8.1% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Psoriasis Treatment market report cover?
The report splits the market by drug class (IL-17 Inhibitors, IL-23 Inhibitors, TNF Inhibitors, Oral Drugs and more), severity (Mild, Moderate to Severe) and end user (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies).
Who are the key players in the Psoriasis Treatment market?
Key players include Johnson & Johnson, AbbVie Inc., Novartis AG, Eli Lilly and Company, UCB and Amgen Inc..
What is driving the Psoriasis Treatment market?
Rising interest in appearance, social media, more affordable treatments and new minimally invasive options are driving the psoriasis Treatment market. More clinics and chains are opening in fast-growing cities.
How many clinical trials on Psoriasis Treatment are running in Middle East?
3 studies are recruiting, active or about to start in Middle East, counted across the 9 countries we report on there, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Middle East. Retrieved 12 Nov 2026.
How much research is published on Psoriasis Treatment?
PubMed lists 926 papers on Psoriasis Treatment added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Pharmaceuticals reports in Middle East

See all

Related on autoimmune diseases and skin and hair

See the topic